Brief: Sprint Bioscience Appoints Johan Emilsson As New CEO
Aug 31 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* JOHAN EMILSSON NEW CEO OF SPRINT BIOSCIENCE
* ANNOUNCES TODAY THAT BOARD HAS APPOINTED JOHAN EMILSSON AS
NEW
CEO
* JOHAN WILL TAKE OFFICE ON 1 OCTOBER 2023
* MATHIAS SKALMSTAD, WHO HAS BEEN ACTING CEO SINCE JANUARY
2023,
WILL CONTINUE TO HOLD ROLE AS CFO OF CO
Source text for Eikon: ID:nMFNjbGjt
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln